Literature DB >> 309867

Human tumor-lymphocyte interaction in vitro. III. T lymphocytes in autologous tumor stimulation (ATS).

F Vánky, E Klein, J Stjernswärd, L Rodriguez, A Péterffy, L Steiner, U Nilsonne.   

Abstract

The T-cell nature of the responding cells in autologous tumor stimulation (ATS) was proven by (1) E-rosette formation of lymphocytes attached to tumor cells during the early period of co-cultivation; (2) blast-transformed E-rosetting cells detectable at the end of the test period (day 6) and (3) the reactivity of T-enriched lymphocyte subset and unresponsiveness of T-depleted fractions. Preparation of tumor suspensions devoid of lymphocytes made it possible to carry out cross-tests between patients. Blastogenesis with allogeneic tumors was rare. The restricted autologous nature of the reaction is a strong indication for genuine tumor-relatedness.

Entities:  

Mesh:

Year:  1978        PMID: 309867     DOI: 10.1002/ijc.2910220607

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Relationship between general or specific immunoreactivity and prognosis in postoperative patients with hepatocellular carcinoma.

Authors:  H Yamasaki; E Okamoto; T Komatsu; Y Manabe; S Shinka
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  DR antigen expression on ovarian carcinoma cells does not correlate with their capacity to elicit an autologous proliferative response.

Authors:  M Di Bello; V Lucchini; S Chiari; R Colleoni; N Colombo; A Mantovani; P Allavena
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells.

Authors:  P Allavena; P Lo Presti; M Di Bello; V Lucchini; A Lissoni; G Zanetta; C Mangioni; A Mantovani
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 4.  Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.

Authors:  B M Vose
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma.

Authors:  M Apiranthitou-Drogari; C Paganin; S Bernasconi; G Losa; A Maneo; N Colombo; A Mantovani; P Allavena
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Histocompatibility antigens on astrocytoma cells.

Authors:  H Hirschberg; L I Endresen; P Wikeby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

7.  Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.

Authors:  F Vánky; A Péterffy; K Böök; J Willems; E Klein; G Klein
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Alloreactive cytotoxicity of interferon-triggered human lymphocytes detected with tumor biopsy targets.

Authors:  F Vánky; E Klein
Journal:  Immunogenetics       Date:  1982-01       Impact factor: 2.846

9.  DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cells.

Authors:  F Vánky; E Klein; J Willems
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 10.  Human autologous tumor-specific T cells in malignant melanoma.

Authors:  C D Platsoucas
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.